Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons

Several studies have demonstrated the therapeutic potential of applying microtubule- (MT-) stabilizing agents (MSAs) that cross the blood-brain barrier to promote axon regeneration and prevent axonal dystrophy in rodent models of spinal cord injury and neurodegenerative diseases. Paradoxically, admi...

Full description

Saved in:
Bibliographic Details
Main Authors: Eun-Hae Jang, Aeri Sim, Sun-Kyoung Im, Eun-Mi Hur
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2016/5056418
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551748607148032
author Eun-Hae Jang
Aeri Sim
Sun-Kyoung Im
Eun-Mi Hur
author_facet Eun-Hae Jang
Aeri Sim
Sun-Kyoung Im
Eun-Mi Hur
author_sort Eun-Hae Jang
collection DOAJ
description Several studies have demonstrated the therapeutic potential of applying microtubule- (MT-) stabilizing agents (MSAs) that cross the blood-brain barrier to promote axon regeneration and prevent axonal dystrophy in rodent models of spinal cord injury and neurodegenerative diseases. Paradoxically, administration of MSAs, which have been widely prescribed to treat malignancies, is well known to cause debilitating peripheral neuropathy and axon degeneration. Despite the growing interest of applying MSAs to treat the injured or degenerating central nervous system (CNS), consequences of MSA exposure to neurons in the central and peripheral nervous system (PNS) have not been thoroughly investigated. Here, we have examined and compared the effects of a brain-penetrant MSA, epothilone B, on cortical and sensory neurons in culture and show that epothilone B exhibits both beneficial and detrimental effects, depending on not only the concentration of drug but also the type and age of a neuron, as seen in clinical settings. Therefore, to exploit MSAs to their full benefit and minimize unwanted side effects, it is important to understand the properties of neuronal MTs and strategies should be devised to deliver minimal effective concentration directly to the site where needed.
format Article
id doaj-art-8d556cc2292646e69e90d9dea7e57bde
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-8d556cc2292646e69e90d9dea7e57bde2025-02-03T06:00:45ZengWileyNeural Plasticity2090-59041687-54432016-01-01201610.1155/2016/50564185056418Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of NeuronsEun-Hae Jang0Aeri Sim1Sun-Kyoung Im2Eun-Mi Hur3Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of KoreaCenter for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of KoreaCenter for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of KoreaCenter for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of KoreaSeveral studies have demonstrated the therapeutic potential of applying microtubule- (MT-) stabilizing agents (MSAs) that cross the blood-brain barrier to promote axon regeneration and prevent axonal dystrophy in rodent models of spinal cord injury and neurodegenerative diseases. Paradoxically, administration of MSAs, which have been widely prescribed to treat malignancies, is well known to cause debilitating peripheral neuropathy and axon degeneration. Despite the growing interest of applying MSAs to treat the injured or degenerating central nervous system (CNS), consequences of MSA exposure to neurons in the central and peripheral nervous system (PNS) have not been thoroughly investigated. Here, we have examined and compared the effects of a brain-penetrant MSA, epothilone B, on cortical and sensory neurons in culture and show that epothilone B exhibits both beneficial and detrimental effects, depending on not only the concentration of drug but also the type and age of a neuron, as seen in clinical settings. Therefore, to exploit MSAs to their full benefit and minimize unwanted side effects, it is important to understand the properties of neuronal MTs and strategies should be devised to deliver minimal effective concentration directly to the site where needed.http://dx.doi.org/10.1155/2016/5056418
spellingShingle Eun-Hae Jang
Aeri Sim
Sun-Kyoung Im
Eun-Mi Hur
Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
Neural Plasticity
title Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
title_full Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
title_fullStr Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
title_full_unstemmed Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
title_short Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
title_sort effects of microtubule stabilization by epothilone b depend on the type and age of neurons
url http://dx.doi.org/10.1155/2016/5056418
work_keys_str_mv AT eunhaejang effectsofmicrotubulestabilizationbyepothilonebdependonthetypeandageofneurons
AT aerisim effectsofmicrotubulestabilizationbyepothilonebdependonthetypeandageofneurons
AT sunkyoungim effectsofmicrotubulestabilizationbyepothilonebdependonthetypeandageofneurons
AT eunmihur effectsofmicrotubulestabilizationbyepothilonebdependonthetypeandageofneurons